Port Catheter Versus Peripherally Inserted Central Catheter For Adjuvant Chemotherapy In Breast Cancer: A Cost-Effectiveness Analysis

Peripherally Inserted Central Catheter ◽

Central Catheter ◽

Port Catheter ◽

A Cost-Effectiveness Analysis of a 6-Month Physical Activity Program Versus Usual Dietary Care During Adjuvant Chemotherapy in Breast Cancer Patients

Value in Health ◽

10.1016/j.jval.2016.03.1588 ◽

2016 ◽

Vol 19 (3) ◽

pp. A149-A150 ◽

Cited By ~ 1

Author(s):

L Perrier ◽

A Foucaut ◽

M Touillaud ◽

AS Kempf-Lepine ◽

M Morelle ◽

...

Keyword(s):

Breast Cancer ◽

Physical Activity ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Physical Activity Program ◽

Breast Cancer Patients ◽

Activity Program ◽

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online

BMC Cancer ◽

10.1186/s12885-017-3603-z ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 5

Author(s):

Beate Jahn ◽

Ursula Rochau ◽

Christina Kurzthaler ◽

Michael Hubalek ◽

Rebecca Miksad ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Early Breast Cancer ◽

Risk Group ◽

Personalized Treatment ◽

Specific Cost ◽

Effectiveness Analysis ◽

Prognostic Tests

P180 A cost effectiveness analysis of adjuvant chemotherapy for node positive early breast cancer in South Africa: docetaxel, doxorubicin and cyclophosphamide (TAC) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC)

The Breast ◽

10.1016/s0960-9776(07)70240-0 ◽

2007 ◽

Vol 16 ◽

pp. S64

Author(s):

B.L. Rapoport ◽

S.D. Moodley ◽

C. Jacobs ◽

R. Pienaar ◽

S. Fourie ◽

...

Keyword(s):

Breast Cancer ◽

South Africa ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Early Breast Cancer ◽

Node Positive ◽

Cost-Effectiveness Analysis Of The Use Of Oncotype Dx To Guide Adjuvant Chemotherapy Decisions In Breast Cancer Patients In Mexico

Value in Health ◽

10.1016/j.jval.2013.03.684 ◽

2013 ◽

Vol 16 (3) ◽

pp. A140

Author(s):

J. Plun-Favreau ◽

S. Suarez ◽

H. Chivardy ◽

L. Pozo

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Oncotype Dx ◽

Breast Cancer Patients ◽

PCN72 GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, ONCOTYPE DX AND CHEMOTHERAPY

Value in Health ◽

10.1016/j.jval.2011.02.927 ◽

2011 ◽

Vol 14 (3) ◽

pp. A167 ◽

Cited By ~ 4

Author(s):

M. Paulden ◽

J. Franek ◽

B. Pham ◽

M. Krahn

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Gene Expression Profiling ◽

Early Breast Cancer ◽

Expression Profiling ◽

Oncotype Dx ◽

PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WITH DOCETAXEL FOR EARLY BREAST CANCER: COST-EFFECTIVENESS ANALYSIS (CEA) OF A DOCETAXEL, DOXORUBICIN AND CYCLOPHOSPHAMIDE REGIMEN (TAC) VERSUS 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN FRANCE

Value in Health ◽

10.1016/s1098-3015(10)67250-6 ◽

2005 ◽

Vol 8 (6) ◽

pp. A36-A37 ◽

Cited By ~ 1

Author(s):

H Miadi-Fargier ◽

C Le Pen ◽

MC Woronoff-Lemsi ◽

JP Guastalla ◽

X Pivot ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Early Breast Cancer ◽

Effectiveness Analysis ◽

Cancer Cost

PCN122 COST-EFFECTIVENESS ANALYSIS OF TRASUTUZUMAB EMTANSINE VERSUS TRASTUZUMAB FOR WOMEN WITH HER2+ ADJUVANT BREAST CANCER IN FRANCE

Value in Health ◽

10.1016/j.jval.2019.09.318 ◽

2019 ◽

Vol 22 ◽

pp. S459 ◽

Cited By ~ 1

Author(s):

A. Gherardi ◽

R. Sellami ◽

B. Tehard ◽

S. Roze

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Adjuvant Breast Cancer

Cost-Effectiveness Analysis: Lymph Node Transfer vs Lymphovenous Bypass for Breast Cancer-Related Lymphedema

Journal of the American College of Surgeons ◽

10.1016/j.jamcollsurg.2021.02.013 ◽

2021 ◽

Author(s):

Yurie Sekigami ◽

Sydney Char ◽

Cate Mullen ◽

Kathryn Huber ◽

Yu Cao ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Breast Cancer Related Lymphedema ◽

Lymph Node Transfer

58P Cost-effectiveness analysis of trastuzumab emtansine versus trastuzumab for Chinese patients with residual invasive HER2-positive early breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.03.072 ◽

2021 ◽

Vol 32 ◽

pp. S45

Author(s):

X. Guan ◽

H-C. Li ◽

Q-J. Chen ◽

B. Hua ◽

J-J. Li ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽

Chinese Patients ◽

Trastuzumab Emtansine ◽

Her2 Positive ◽

Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1080/14737167.2021.1909478 ◽

2021 ◽

pp. 1-10

Author(s):

Carlos Henrique Botelho ◽

Maria Del Pilar Estevez-Diz ◽

Alessandro Gonçalves Campolina

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽